[Characteristic analysis of patients with type 2 diabetes mellitus combined with advanced stage chronic liver disease: a community population-based cross-sectional study in Heping District, Shenyang City (CHESS-LN 2101)].

医学 内科学 慢性肝病 脂肪肝 腰围 糖尿病 人口 胃肠病学 肝病 横断面研究 体质指数 2型糖尿病 非酒精性脂肪肝 肝硬化 疾病 病理 环境卫生 内分泌学
作者
C Lyu,Wenjin Fu,Ye Gu,L S Wang,X M Wang,X Liu,J M Qian,Z Tao,Y Chen,C Liu,R L He,X Guan,Y Wang,Y Wang,X L Qi
出处
期刊:PubMed 卷期号:30 (11): 1194-1200
标识
DOI:10.3760/cma.j.cn501113-20210810-00390
摘要

Objective: To investigate the prevalence and independent risk factors of non-alcoholic fatty liver disease (NAFLD) and advanced chronic liver disease among the type 2 diabetes mellitus (T2DM) population in the Shenyang community, so as to provide evidence for the prevention and control of T2DM combined with NAFLD. Methods: This cross-sectional study was conducted in July 2021. 644 T2DM cases from 13 communities in Heping District, Shenyang City were selected. All the surveyed subjects underwent physical examination (measurements of height, body mass index, neck circumference, waist circumference, abdominal circumference, hip circumference, and blood pressure), infection screening (excluding hepatitis B and C, AIDS, and syphilis), random fingertip blood glucose, controlled attenuation parameter (CAP), and liver stiffness measurement (LSM). The study subjects were divided into the non-advanced chronic liver disease group and the advanced chronic liver disease group according to whether the LSM value was greater than 10 kPa. Cirrhotic portal hypertension development was indicated in patients with LSM ≥ 15 kPa. The comparison of multiple mean values among the sample groups was performed by analysis of variance when the normal distribution was met. Results: In the T2DM community population, there were 401 cases (62.27%) combined with NAFLD, 63 cases (9.78%) combined with advanced chronic liver disease, and 14 cases (2.17%) combined with portal hypertension. There were 581 cases in the non-advanced chronic liver disease group and 63 cases (9.78%) in the advanced chronic liver disease group (LSM ≥10 kPa), including 49 cases (7.61%) with 10 kPa≤LSM<15 kPa, 11 cases (1.71%) with 15 kPa ≤LSM<25 kPa, and 3 cases (0.47%) with LSM ≥ 25 kPa. Age, body mass, body mass index, neck circumference, waist circumference, hip circumference, waist-to-height ratio, systolic blood pressure, and CAP were all statistically different between the non-advanced chronic liver disease group and the advanced chronic liver disease group (F=-1.983,-2.598,-4.091,-2.062,-3.909, -4.581,-4.295,-2.474, and -5.191, respectively; P<0.05). There was a statistically significant difference in terms of whether or not there was combined cerebrovascular disease (2=4.632, P=0.031); however, there were no statistically significant differences in terms of lifestyle, diabetes complications, and other complications (P>0.05). Conclusion: Patients with T2DM have a higher prevalence of NAFLD (62.27%) than those with advanced chronic liver disease (9.78%). 2.17% of T2DM cases in the community may not have had early diagnosis and early intervention, and they might have been combined with cirrhotic portal hypertension. So, the management of these patients should be strengthened.目的: 探讨沈阳社区2型糖尿病(T2DM)人群中非酒精性脂肪性肝病(NAFLD)、进展期慢性肝病的患病率和独立危险因素,为社区T2DM合并NAFLD的预防及控制提供依据。 方法: 于2021年7月在沈阳市和平区13个社区,入选T2DM患者644例进行横断面研究,对所有调查对象进行体格检查(测量身高、体质量、颈围、腰围、腹围、臀围、血压)、传染筛查(排除乙型肝炎、丙型肝炎、艾滋病、梅毒)、随机指尖血糖以及受控衰减参数(CAP)、肝脏硬度值(LSM)检查。研究对象根据LSM值是否大于10 kPa分为无进展期慢性肝病组和进展期慢性肝病组,其中LSM≥15 kPa提示患者发展为肝硬化门静脉高压。样本中组间多个均数的比较,符合正态分布时采用方差分析。 结果: 在社区T2DM人群中,合并NAFLD患者401例(62.27%),合并进展期慢性肝病患者63例(9.78%),合并门静脉高压者14例(2.17%)。无进展期慢性肝病组581例;进展期慢性肝病(LSM≥10 kPa)组[63例(9.78%)],其中:10 kPa≤LSM<15 kPa 49例(7.61%),15 kPa≤LSM<25 kPa 11例(1.71%),LSM≥25 kPa者3例(0.47%)。无进展期慢性肝病组和进展期慢性肝病组在年龄、体质量、体质量指数、颈围、腰围、臀围、腰高比、收缩压、CAP比较,差异均有统计学意义(F值分别为-1.983、-2.598、-4.091、-2.062、-3.909、-4.581、-4.295、-2.474、-5.191;P值均<0.05);两组在是否合并脑血管疾病上差异有统计学意义(χ2=4.632,P=0.031);而在生活习惯、糖尿病合并症及其他并发症方面比较,P值均>0.05,差异均无统计学意义。 结论: 在T2DM中NAFLD的患病率较高,为62.27%,进展期慢性肝病的患病率为9.78%,其中2.17%社区T2DM患者可能未早期诊断早期干预,已合并肝硬化门静脉高压,应加强该部分患者的管理。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助酷酷飞烟采纳,获得10
刚刚
meng发布了新的文献求助30
1秒前
1秒前
完美小蘑菇完成签到,获得积分10
1秒前
兰是一个信仰完成签到,获得积分10
1秒前
潇湘雪月发布了新的文献求助10
4秒前
YJ888发布了新的文献求助10
4秒前
azusa完成签到,获得积分10
8秒前
昔年若许完成签到,获得积分10
15秒前
18秒前
19秒前
21秒前
高手发布了新的文献求助10
21秒前
善学以致用应助1WSQARFGRDSX采纳,获得10
22秒前
ZZZ完成签到,获得积分10
23秒前
ZZZ发布了新的文献求助10
25秒前
一一完成签到 ,获得积分10
25秒前
hp发布了新的文献求助10
27秒前
28秒前
姚世娇完成签到 ,获得积分10
30秒前
FashionBoy应助高手采纳,获得10
31秒前
meng完成签到,获得积分10
32秒前
chennn完成签到,获得积分10
32秒前
34秒前
35秒前
晗月完成签到,获得积分10
35秒前
情怀应助如意枫叶采纳,获得10
36秒前
量子星尘发布了新的文献求助10
38秒前
Akim应助SS采纳,获得10
39秒前
张雷应助清新的夜蕾采纳,获得20
39秒前
chennn发布了新的文献求助10
39秒前
罗一完成签到,获得积分10
41秒前
43秒前
丘比特应助wu采纳,获得10
46秒前
俏皮芷蕊发布了新的文献求助30
46秒前
称心的菲鹰完成签到,获得积分10
47秒前
碧蓝问安发布了新的文献求助10
48秒前
48秒前
打打应助ZZZ采纳,获得10
50秒前
54秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989242
求助须知:如何正确求助?哪些是违规求助? 3531393
关于积分的说明 11253753
捐赠科研通 3270010
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136